BCANTT25

Ashish M. Kamat: Defining New Endpoints and Designing Next-Generation Trials in MIBC

Ashish M. Kamat, Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD Anderson Cancer Center, shared on X:

“Join us for joint summit by the International Bladder Cancer Group (IBCG) and Global Society of Rare Genitourinary Tumors (GSRGT) at San Raffaele Hospital.

Defining New Endpoints and Designing Next-Generation Trials of Perioperative Therapies in Muscle-Invasive Bladder Cancer.

Kudos to Andrea Necchi for his vision and leadership in making this happen!”

Next-Generation Trials